Table: Wakamoto Pharm - Q1 parent results

Wakamoto Pharmaceutical

01/08/2019 07:00

Aug 1 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2019        Jun 30, 2018      Mar 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             2.74                2.70              11.30     
                 (+1.5 pct)          (-0.6 pct)        (+5.2 pct)   
  Operating     loss 251 mln           137 mln          loss 1.80   
                                     (+2.0 pct)                     
  Recurring     loss 232 mln           151 mln          loss 1.80   
                                     (+0.8 pct)                     
  Net           loss 289 mln           100 mln          loss 1.30   
                                     (+0.9 pct)                     
  EPS           loss 8.35 yen         2.89 yen       loss 37.46 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T